Infratil Limited (ASX:IFT)
Australia · Delayed Price · Currency is AUD 10.70
-0.40 (-3.60%)
Jul 31, 2025, 4:10 PM AEST
CTI BioPharma Revenue
In the fiscal year ending March 31, 2025, Infratil had annual revenue of 3.85B NZD with 22.69% growth. Infratil had revenue of 2.03B in the half year ending March 31, 2025.
Revenue
3.85B NZD
Revenue Growth
+22.69%
P/S Ratio
2.98
Revenue / Employee
544.35K NZD
Employees
7,076
Market Cap
10.45B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.85B | 712.30M | 22.69% |
| Mar 31, 2024 | 3.14B | 1.29B | 70.15% |
| Mar 31, 2023 | 1.85B | 547.70M | 42.22% |
| Mar 31, 2022 | 1.30B | 889.20M | 217.83% |
| Mar 31, 2021 | 408.20M | -694.50M | -62.98% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Transurban Group | 3.83B |
| Brambles | 11.00B |
| SGH Limited | 10.85B |
| Qantas Airways | 22.94B |
| ALS Limited | 3.00B |
| Reece | 8.97B |
| Qube Holdings | 3.75B |
| Atlas Arteria | 145.90M |
Infratil News
- 23 days ago - $30 billion blast-off: Why Rocket Lab just hit an all-time high and the 32,000 Kiwis along for the ride - NZ Herald
- 5 weeks ago - Data centre giant CDC calls in Barrenjoey for mega debt package - The Australian Financial Review